Print
Email
Biogen Idec Inc has a market cap of $29.46 billion; its shares were traded at around $121.26 with a P/E ratio of 21.1 and P/S ratio of 6.3. Biogen Idec Inc had an annual average earning growth of 25.3% over the past 5 years.
CFO Recent Trades:
- Executive VP and CFO Paul J Clancy sold 20,244 shares of BIIB stock on 01/03/2012 at the average price of 112.35. Paul J Clancy owns at least 21,168 shares after this. The price of the stock has increased by 7.93% since.
This is the insider trade history vs. stock price of BIIB. For the complete insider trading history of BIIB, click here.
Directors and Officers Recent Trades:
- Director Nancy Leaming sold 3,000 shares of BIIB stock on 01/20/2012 at the average price of 118. Nancy Leaming owns at least 6,335 shares after this. The price of the stock has increased by 2.76% since.
- Director Nancy Leaming sold 3,000 shares of BIIB stock on 01/06/2012 at the average price of 116. Nancy Leaming owns at least 6,335 shares after this. The price of the stock has increased by 4.53% since.
- Director Eric K Rowinsky sold 12,992 shares of BIIB stock on 01/06/2012 at the average price of 116. Eric K Rowinsky owns at least 9,135 shares after this. The price of the stock has increased by 4.53% since.
- Director Nancy Leaming sold 4,000 shares of BIIB stock on 01/03/2012 at the average price of 114. Nancy Leaming owns at least 6,335 shares after this. The price of the stock has increased by 6.37% since.
- Director Stephen A Sherwin sold 2,500 shares of BIIB stock on 12/19/2011 at the average price of 110.88. Stephen A Sherwin owns at least 6,635 shares after this. The price of the stock has increased by 9.36% since.
For the complete insider trading history of BIIB, click here.
Subscribe RSS
